Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 7, 2002, Pages 3300-3308

  Wang, Tzu Hao ^a,b   Horng, Shang Gwo ^a,b   Chang, Chia Lin ^a,b   Wu, Hsien Ming ^a,b   Tsai, Yi Ju ^a,b   Wang, Hsin Shih ^a,b   Soong, Yung Kuei ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; TYROSINE KINASE RECEPTOR; VASCULOTROPIN;

ADULT; ARTICLE; ASCITES; AUTOCRINE EFFECT; BLOOD VESSEL PERMEABILITY; CLINICAL FEATURE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; GRANULOSA CELL; HUMAN; MAJOR CLINICAL STUDY; OVARY CYCLE; OVARY DISEASE; OVARY FOLLICLE MATURATION; PLEURA EFFUSION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

FALLOPIA;

EID: 0036328484     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.7.8651     Document Type: Article

References (36)

1. Human vascular permeability factor. Isolation from U937 cells
2. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome
3. Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: Role of early pregnancy and ovarian gonadotropin stimulation
4. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome
5. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development
6. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome
7. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization
8. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome
9. Effect of a gonadotropin-releasing hormone agonist on luteinizing hormone receptors and steroidogenesis in ovarian cells
10. IGFs and IGF-binding proteins in the regulation of human ovarian and endometrial function
11. Changes in mRNA expression of insulin-like growth factors and insulin-like growth factor-binding proteins in ovarian granulosa cells after cotreatment with growth hormone in low responders
12. Cyclic changes in serum levels of insulin-like growth factor binding protein-1 in women treated with clomiphene citrate and tamoxifen
13. Distinction between early and late ovarian hyperstimulation syndrome
14. Ovarian hyperstimulation syndrome: An update review
15. Elevation of insulin-like growth factor-binding protein-1 mRNA expression following hormone replacement therapy
16. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization
17. Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome
18. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
19. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells
20. Increased capillary permeability induced by human follicular fluid: A hypothesis for an ovarian origin of the hyperstimulation syndrome
21. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor
22. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast
23. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
24. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
25. Expression and localisation of vascular endothelial growth factor and basic fibroblast growth factor during the final growth of bovine ovarian follicles
26. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF
27. Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential
28. Expression, production, and secretion of vascular endothelial growth factor and interleukin-6 by granulosa cells is comparable in women with and without endometriosis
29. Lower implantation rates in high responders: Evidence for an altered endocrine milieu during the preimplantation period
30. Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen
31. High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome
32. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: Relevance to ovarian hyperstimulation syndrome and polycystic ovaries
33. Further evidence of increased aromatase activity in granulosa luteal cells from polycystic ovary
34. Insulin and insulin-like growth factor-I and -II modulate human granulosalutein cell steroidogenesis: Enhancement of steroidogenic acute regulatory protein (StAR) expression
35. Insulin preincubation enhances insulin-like growth factor-II (IGF-II) action on steroidogenesis in human granulosa cells
36. The role of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in the control of human fetal growth